Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Sees Significant Increase in Short Interest

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) was the target of a large increase in short interest in December. As of December 31st, there was short interest totalling 1,200 shares, an increase of 50.0% from the December 15th total of 800 shares. Based on an average daily volume of 200 shares, the days-to-cover ratio is currently 6.0 days.

Santhera Pharmaceuticals Stock Performance

OTCMKTS:SPHDF remained flat at $9.42 during trading hours on Friday. The company has a fifty day moving average of $10.24 and a 200-day moving average of $11.19. Santhera Pharmaceuticals has a 12 month low of $9.42 and a 12 month high of $9.42.

Santhera Pharmaceuticals Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).